Page 3 - Acrivon Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Acrivon Therapeutics shares climb 14% on plans to present cancer-test data

Shares of Acrivon Therapeutics advanced in post-market trading after the biopharmaceutical company said it would present clinical trial data in connection…

Acrivon therapeuticsReaking news

Acrivon Therapeutics (NASDAQ:ACRV) Price Target Raised to $17 00 at JMP Securities

Acrivon Therapeutics (NASDAQ:ACRV) Price Target Raised to $17 00 at JMP Securities
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerExchange commissionExchange traded conceptsPerceptive advisors llcAcrivon therapeutics incAcrivon therapeuticsGet free reportTraded conceptsFree reportAcrivon predictive precision proteomicsAcrivon therapeutics daily

JMP Securities Increases Acrivon Therapeutics (NASDAQ:ACRV) Price Target to $17 00

JMP Securities Increases Acrivon Therapeutics (NASDAQ:ACRV) Price Target to $17 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerAcrivon therapeutics incAcrivon therapeutics company profileExchange traded conceptsSecurities exchange commissionPerceptive advisors llcAcrivon therapeuticsGet free reportTraded conceptsFree reportAcrivon predictive precision proteomicsAcrivon therapeutics daily

Acrivon Therapeutics (ACRV) Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event

Acrivon Therapeutics (ACRV) Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kristina massonPeter blume jensenAcrivon therapeutics incCompany provides programAcrivon therapeuticsAcrivon predictive precision proteomicsProvides programData highlights

Acrivon Therapeutics Reports Initial Positive Clinical Data For ACR-368 And Pipeline Program Progress Today At Corporate R&D Event

Acrivon Therapeutics Reports Initial Positive Clinical Data For ACR-368 And Pipeline Program Progress Today At Corporate R&D Event
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Kristina massonPeter blume jensenExchange commissionDrug administrationAcrivon therapeutics incCompany provides programAcrivon predictive precision proteomicsAcrivon therapeuticsProvides programData highlightsFast trackBreakthrough devicePrivate securities litigation reform act